Cabergoline in Metastatic Breast Cancer

Clinical trial NCT01730729 · COMPLETED

Trial details

NCT number: NCT01730729
Sponsor: Northwestern University
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Recurrent Breast Cancer Stage IV Breast Cancer

Start date: 2013-02-11
Primary completion: 2015-12-15
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.